| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |